Skip to main content

Pharmacology of the Lower Urinary Tract

  • Reference work entry
  • First Online:
Handbook of Neurourology

Abstract

The functions of the lower urinary tract, to store and periodically release urine, are dependent on the activity of smooth and striated muscles in the urinary bladder, urethra, and external urethral sphincter. This activity is in turn controlled by neural circuits in the brain, spinal cord, and peripheral ganglia. Various neurotransmitters, including acetylcholine, norepinephrine, dopamine, serotonin, excitatory and inhibitory amino acids, adenosine triphosphate, nitric oxide, and neuropeptides, both in the periphery and the central nervous system have been implicated in the neural regulation of the lower urinary tract. Injuries or diseases of the nervous system, as well as drugs and disorders of the peripheral organs, can produce voiding dysfunctions such as urinary frequency, urgency, pain and incontinence, or inefficient voiding and urinary retention. This chapter reviews recent advances in our understanding of the pharmacology in the control of lower urinary tract function and the targets for drug therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 999.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 999.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. P. Abrams, C. Kelleher, D. Staskin, T. Rechberger, R. Kay, R. Martina, D. Newgreen, A. Paireddy, R. van Maanen, A. Ridder, Combination treatment with mirabegron and solifenacin in patients with overactive bladder: Efficacy and safety results from a randomised, double-blind, dose-ranging, phase 2 study (Symphony). Eur. Urol. 67(3), 577–588 (2015)

    Article  CAS  PubMed  Google Scholar 

  2. N. Aizawa, Y. Homma, Y. Igawa, Effects of L-arginine, mirabegron, and oxybutynin on the primary bladder afferent nerve activities synchronized with reflexic, rhythmic bladder contractions in the rat. Neurourol. Urodyn. 34(4), 368–374 (2015)

    Article  CAS  PubMed  Google Scholar 

  3. A. Albanese, P. Jenner, C.D. Marsden, J.D. Stephenson, Bladder hyperreflexia induced in marmosets by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Neurosci. Lett. 87(1–2), 46–50 (1988)

    Article  CAS  PubMed  Google Scholar 

  4. K.-E. Andersson, Pharmacology of lower urinary tract smooth muscles and penile erectile tissues. [Review]. Pharmacol. Rev. 45, 253–308 (1993)

    Google Scholar 

  5. K.E. Andersson, A. Arner, Urinary bladder contraction and relaxation: Physiology and pathophysiology. Physiol. Rev. 84(3), 935–986 (2004)

    Article  CAS  PubMed  Google Scholar 

  6. K.E. Andersson, A. Garcia Pascual, K. Persson, A. Forman, A. Tottrup, Electrically-induced, nerve-mediated relaxation of rabbit urethra involves nitric oxide. J. Urol. 147(1), 253–259 (1992)

    Article  CAS  PubMed  Google Scholar 

  7. K.E. Andersson, K. Persson, Nitric oxide synthase and the lower urinary tract: Possible implications for physiology and pathophysiology. Scand. J. Urol. Nephrol. Suppl. 175, 43–53 (1995)

    CAS  PubMed  Google Scholar 

  8. A. Apostolidis, P. Dasgupta, P. Denys, S. Elneil, C.J. Fowler, A. Giannantoni, G. Karsenty, H. Schulte-Baukloh, B. Schurch, J.J. Wyndaele, Recommendations on the use of botulinum toxin in the treatment of lower urinary tract disorders and pelvic floor dysfunctions: A European consensus report. Eur. Urol (2008)

    Google Scholar 

  9. A. Apostolidis, C.J. Fowler, The use of botulinum neurotoxin type A (BoNTA) in urology. J. Neural Transm. 115(4), 593–605 (2008)

    Article  CAS  PubMed  Google Scholar 

  10. A. Apostolidis, R. Popat, Y. Yiangou, D. Cockayne, A.P. Ford, J.B. Davis, P. Dasgupta, C.J. Fowler, P. Anand, Decreased sensory receptors P2X3 and TRPV1 in suburothelial nerve fibers following intradetrusor injections of botulinum toxin for human detrusor overactivity. J. Urol. 174(3), 977–982 (2005).; discussion 982–973

    Article  CAS  PubMed  Google Scholar 

  11. A. Apostolidis, M.S. Rahnama'i, C. Fry, R. Dmochowski, A. Sahai, Do we understand how botulinum toxin works and have we optimized the way it is administered to the bladder? ICI-RS 2014. Neurourol. Urodyn. 35(2), 293–298 (2016)

    Article  CAS  PubMed  Google Scholar 

  12. B.C. Bennett, M.N. Kruse, J.R. Roppolo, H.D. Flood, M. Fraser, W.C. de Groat, Neural control of urethral outlet activity in vivo: Role of nitric oxide. J. Urol. 153(6), 2004–2009 (1995)

    Article  CAS  PubMed  Google Scholar 

  13. M.B. Bridgeman, N.J. Friia, C. Taft, M. Shah, Mirabegron: beta3-adrenergic receptor agonist for the treatment of overactive bladder. Ann. Pharmacother. 47(7–8), 1029–1038 (2013)

    Article  PubMed  Google Scholar 

  14. G. Burnstock, P2 purinoceptors: Historical perspective and classification. Ciba Found. Symp. 198, 1–28 (1996).; discussion 29–34

    CAS  PubMed  Google Scholar 

  15. G. Burnstock, Handbook of Experimental Pharmacology on "Purinergic and Pyrimidinergic Signalling". M. Abbracchio and W. Williams. (Springer-Verlag, Berlin, 2000)

    Google Scholar 

  16. G. Burnstock, Purine-mediated signalling in pain and visceral perception. Trends Pharmacol. Sci. 22(4), 182–188 (2001)

    Article  CAS  PubMed  Google Scholar 

  17. G. Burnstock, B. Dumsday, A. Smythe, Atropine resistant excitation of the urinary bladder: The possibility of transmission via nerves releasing a purine nucleotide. Br. J. Pharmacol. 44(3), 451–461 (1972)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. M.A. Cantrell, J. Baye, S.M. Vouri, Tadalafil: A phosphodiesterase-5 inhibitor for benign prostatic hyperplasia. Pharmacotherapy 33(6), 639–649 (2013)

    Article  CAS  PubMed  Google Scholar 

  19. M.B. Chancellor, S.A. Kaplan, J.G. Blaivas, The cholinergic and purinergic components of detrusor contractility in a whole rabbit bladder model. J. Urol. 148(3), 906–909 (1992)

    Article  CAS  PubMed  Google Scholar 

  20. S.Y. Chen, S.D. Wang, C.L. Cheng, J.S. Kuo, W.C. De Groat, C.Y. Chai, Glutamate activation of neurons in CV-reactive areas of cat brain stem affects urinary bladder motility. Am. J. Phys. 265(4 Pt 2), F520–F529 (1993)

    CAS  Google Scholar 

  21. H. Chiba, T. Mitsui, T. Kitta, Y. Ohmura, K. Moriya, Y. Kanno, M. Yoshioka, N. Shinohara, The role of serotonergic mechanism in the rat prefrontal cortex for controlling the micturition reflex: An in vivo microdialysis study. Neurourol. Urodyn. 35(8), 902–907 (2015)

    Article  PubMed  Google Scholar 

  22. D.A. Cockayne, P.M. Dunn, Y. Zhong, W. Rong, S.G. Hamilton, G.E. Knight, H.Z. Ruan, B. Ma, P. Yip, P. Nunn, S.B. McMahon, G. Burnstock, A.P. Ford, P2X2 knockout mice and P2X2/P2X3 double knockout mice reveal a role for the P2X2 receptor subunit in mediating multiple sensory effects of ATP. J. Physiol. 567(Pt 2), 621–639 (2005)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. D.A. Cockayne, S.G. Hamilton, Q.M. Zhu, P.M. Dunn, Y. Zhong, S. Novakovic, A.B. Malmberg, G. Cain, A. Berson, L. Kassotakis, L. Hedley, W.G. Lachnit, G. Burnstock, S.B. McMahon, A.P. Ford, Urinary bladder hyporeflexia and reduced pain-related behaviour in P2X3-deficient mice. Nature 407(6807), 1011–1015 (2000)

    Article  CAS  PubMed  Google Scholar 

  24. B.R. DasGupta, Structures of botulinum neurotoxin, its functional domains, and perspectives on the crystalline type A toxin, in Therapy with Botulinum Toxin, ed. by J. Jankovic, M. Hallet, (Dekker, New York, Marcel, 1994), pp. 15–39

    Google Scholar 

  25. W.C. de Groat, Influence of central serotonergic mechanisms on lower urinary tract function. Urology 59(5 Suppl 1), 30–36 (2002)

    Article  PubMed  Google Scholar 

  26. W.C. de Groat, D. Griffiths, N. Yoshimura, Neural control of the lower urinary tract. Compr. Physiol. 5(1), 327–396 (2015)

    PubMed  PubMed Central  Google Scholar 

  27. W.C. De Groat, J.R. Roppolo, N. Yoshimura, K. Sugaya, in Neural control of the urinary bladder and colon, ed. by Y. Taché, D. Wingate, T. Burks, (CRC Press, Boca Raton, FL, 1993), pp. 167–190

    Google Scholar 

  28. W.C. de Groat, R.J. Theobald, Reflex activation of sympathetic pathways to vesical smooth muscle and parasympathetic ganglia by electrical stimulation of vesical afferents. J. Physiol. Lond. 259, 223–237 (1976)

    Article  PubMed  PubMed Central  Google Scholar 

  29. W.C. de Groat, N. Yoshimura, Pharmacology of the lower urinary tract. Annu. Rev. Pharmacol. Toxicol. 41, 691–721 (2001)

    Article  PubMed  Google Scholar 

  30. W.C. de Groat, M. Yoshiyama, A.G. Ramage, T. Yamamoto, G.T. Somogyi, Modulation of voiding and storage reflexes by activation of alpha1-adrenoceptors. Eur. Urol. 36 Suppl 1, 68–73 (1999)

    Article  PubMed  Google Scholar 

  31. D.D. Dykstra, A.A. Sidi, Treatment of detrusor-sphincter dyssynergia with botulinum a toxin: A double-blind study. Arch. Phys. Med. Rehabil. 71(1), 24–26 (1990)

    CAS  PubMed  Google Scholar 

  32. D.D. Dykstra, A.A. Sidi, A.B. Scott, J.M. Pagel, G.D. Goldish, Effects of botulinum a toxin on detrusor-sphincter dyssynergia in spinal cord injury patients. J. Urol. 139(5), 919–922 (1988)

    Article  CAS  PubMed  Google Scholar 

  33. M.J. Espey, H.J. Du, J.W. Downie, Serotonergic modulation of spinal ascending activity and sacral reflex activity evoked by pelvic nerve stimulation in cats. Brain Res. 798(1–2), 101–108 (1998)

    Article  CAS  PubMed  Google Scholar 

  34. D.R. Ferguson, I. Kennedy, T.J. Burton, ATP is released from rabbit urinary bladder epithelial cells by hydrostatic pressure changes–a possible sensory mechanism? J. Physiol. 505(Pt 2), 503–511 (1997)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. M. Gacci, G. Corona, M. Salvi, L. Vignozzi, K.T. McVary, S.A. Kaplan, C.G. Roehrborn, S. Serni, V. Mirone, M. Carini, M. Maggi, A systematic review and meta-analysis on the use of phosphodiesterase 5 inhibitors alone or in combination with alpha-blockers for lower urinary tract symptoms due to benign prostatic hyperplasia. Eur. Urol. 61(5), 994–1003 (2012)

    Article  CAS  PubMed  Google Scholar 

  36. L. Guarneri, M. Ibba, R. Testa, A. Leonardi, The effect of mCPP on bladder voiding contractions in rats are mediated by the 5HT2A/5-HT2C receptors. Neurourol. Urodyn. 15, 316 (1996)

    Google Scholar 

  37. K. Hashimoto, T. Oyama, T. Sugiyama, Y.C. Park, T. Kurita, Neuronal excitation in the ventral tegmental area modulates the micturition reflex mediated via the dopamine D1 and D2 receptors in rats. J. Pharmacol. Sci. 92(2), 143–148 (2003)

    Article  CAS  PubMed  Google Scholar 

  38. X.H. Hou, M. Hyun, J. Taranda, K.W. Huang, E. Todd, D. Feng, E. Atwater, D. Croney, M.L. Zeidel, P. Osten, B.L. Sabatini, Central control circuit for context-dependent micturition. Cell 167(1), 73–86 e12 (2016)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Y. Igawa, A. Mattiasson, K.E. Andersson, Effects of GABA-receptor stimulation and blockade on micturition in normal rats and rats with bladder outflow obstruction. J. Urol. 150(2 Pt 1), 537–542 (1993)

    Article  CAS  PubMed  Google Scholar 

  40. Y. Igawa, X. Zhang, O. Nishizawa, M. Umeda, A. Iwata, M.M. Taketo, T. Manabe, M. Matsui, K.E. Andersson, Cystometric findings in mice lacking muscarinic M2 or M3 receptors. J. Urol. 172(6 Pt 1), 2460–2464 (2004)

    Article  CAS  PubMed  Google Scholar 

  41. R. Inoue, A.F. Brading, The properties of the ATP-induced depolarization and current in single cells isolated from the guinea-pig urinary bladder. Br. J. Pharmacol. 100(3), 619–625 (1990)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. T. Inoue, G. Gabella, A vascular network closely linked to the epithelium of the urinary bladder of the rat. Cell Tissue Res. 263(1), 137–143 (1991)

    Article  CAS  PubMed  Google Scholar 

  43. T. Ito, R. Sakakibara, K. Nakazawa, T. Uchiyama, T. Yamamoto, Z. Liu, E. Shimizu, T. Hattori, Effects of electrical stimulation of the raphe area on the micturition reflex in cats. Neuroscience 142(4), 1273–1280 (2006)

    Article  CAS  PubMed  Google Scholar 

  44. S. Kanie, O. Yokoyama, K. Komatsu, K. Kodama, S. Yotsuyanagi, S. Niikura, Y. Nagasaka, K.I. Miyamoto, M. Namiki, GABAergic contribution to rat bladder hyperactivity after middle cerebral artery occlusion. Am. J. Physiol. Regul. Integr. Comp. Physiol. 279(4), R1230–R1238 (2000)

    Article  CAS  PubMed  Google Scholar 

  45. N. Kawamorita, Y. Kaiho, M. Miyazato, Y. Arai, N. Yoshimura, Roles of the spinal glutamatergic pathway activated through alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptors and its interactions with spinal noradrenergic and serotonergic pathways in the rat urethral continence mechanisms. Neurourol. Urodyn. 34(5), 475–481 (2014)

    Article  PubMed  Google Scholar 

  46. G.M. Keating, Silodosin: A review of its use in the treatment of the signs and symptoms of benign prostatic hyperplasia. Drugs 75(2), 207–217 (2015)

    Article  CAS  PubMed  Google Scholar 

  47. T. Kitta, M.B. Chancellor, W.C. de Groat, S. Kuno, K. Nonomura, N. Yoshimura, Suppression of bladder overactivity by adenosine A2A receptor antagonist in a rat model of Parkinson disease. J. Urol. 187(5), 1890–1897 (2012)

    Article  CAS  PubMed  Google Scholar 

  48. T. Kitta, I. Yabe, I. Takahashi, M. Matsushima, H. Sasaki, N. Shinohara, Clinical efficacy of istradefylline on lower urinary tract symptoms in Parkinson's disease. Int. J. Urol. 23(10), 893–894 (2016)

    Article  CAS  PubMed  Google Scholar 

  49. H. Kontani, T. Inoue, T. Sakai, Dopamine receptor subtypes that induce hyperactive urinary bladder response in anesthetized rats. Jpn. J. Pharmacol. 54(4), 482–486 (1990)

    Article  CAS  PubMed  Google Scholar 

  50. H.Y. Lee, M. Bardini, G. Burnstock, Distribution of P2X receptors in the urinary bladder and the ureter of the rat. J. Urol. 163(6), 2002–2007 (2000)

    Article  CAS  PubMed  Google Scholar 

  51. K.S. Lee, Y.G. Na, T. Dean-McKinney, A.P. Klausner, J.B. Tuttle, W.D. Steers, Alterations in voiding frequency and cystometry in the clomipramine induced model of endogenous depression and reversal with fluoxetine. J. Urol. 170(5), 2067–2071 (2003)

    Article  CAS  PubMed  Google Scholar 

  52. R.M. Levin, A.J. Wein, Neurophysiology and Neuropharmacology. Bladder J. Fitzpatrick and R. Krane. (Churchill Livingstone, New York, 1995), pp. 47–70

    Google Scholar 

  53. M. Matsui, D. Motomura, T. Fujikawa, J. Jiang, S. Takahashi, T. Manabe, M.M. Taketo, Mice lacking M2 and M3 muscarinic acetylcholine receptors are devoid of cholinergic smooth muscle contractions but still viable. J. Neurosci. 22(24), 10627–10632 (2002)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  54. M. Matsui, D. Motomura, H. Karasawa, T. Fujikawa, J. Jiang, Y. Komiya, S. Takahashi, M.M. Taketo, Multiple functional defects in peripheral autonomic organs in mice lacking muscarinic acetylcholine receptor gene for the M3 subtype. Proc. Natl. Acad. Sci. U. S. A. 97(17), 9579–9584 (2000)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  55. S.B. McMahon, K. Spillane, Brain stem influences on the parasympathetic supply to the urinary bladder of the cat. Brain Res. 234(2), 237–249 (1982)

    Article  CAS  PubMed  Google Scholar 

  56. G. McMurray, N. Dass, K. Ho, A.F. Brading, Purinergic mechanisms in primate urinary bladder. Br. J. Urol. 80, 182 (1997)

    Google Scholar 

  57. M.C. Michel, W. Vrydag, Alpha1-, alpha2- and beta-adrenoceptors in the urinary bladder, urethra and prostate. Br. J. Pharmacol. 147 Suppl 2, S88–119 (2006)

    PubMed  Google Scholar 

  58. M. Miyazato, K. Sasatomi, S. Hiragata, K. Sugaya, M.B. Chancellor, W.C. de Groat, N. Yoshimura, GABA receptor activation in the lumbosacral spinal cord decreases detrusor overactivity in spinal cord injured rats. J. Urol. 179(3), 1178–1183 (2008a)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  59. M. Miyazato, K. Sasatomi, S. Hiragata, K. Sugaya, M.B. Chancellor, W.C. de Groat, N. Yoshimura, Suppression of detrusor-sphincter dysynergia by GABA-receptor activation in the lumbosacral spinal cord in spinal cord-injured rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 295(1), R336–R342 (2008b)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  60. M. Miyazato, K. Sugaya, S. Nishijima, K. Ashitomi, T. Hatano, Y. Ogawa, Inhibitory effect of intrathecal glycine on the micturition reflex in normal and spinal cord injury rats. Exp. Neurol. 183(1), 232–240 (2003)

    Article  CAS  PubMed  Google Scholar 

  61. M. Miyazato, K. Sugaya, S. Nishijima, K. Ashitomi, M. Morozumi, Y. Ogawa, Dietary glycine inhibits bladder activity in normal rats and rats with spinal cord injury. J. Urol. 173(1), 314–317 (2005)

    Article  CAS  PubMed  Google Scholar 

  62. T. Morita, M. Ando, K. Kihara, H. Oshima, Species differences in cAMP production and contractile response induced by beta-adrenoceptor subtypes in urinary bladder smooth muscle. Neurourol. Urodyn. 12(2), 185–190 (1993)

    Article  CAS  PubMed  Google Scholar 

  63. T. Nishimoto, J. Latifpour, M.A. Wheeler, M. Yoshida, R.M. Weiss, Age-dependent alterations in beta-adrenergic responsiveness of rat detrusor smooth muscle. J. Urol. 153(5), 1701–1705 (1995)

    Article  CAS  PubMed  Google Scholar 

  64. M. Nomiya, O. Yamaguchi, A quantitative analysis of mRNA expression of alpha 1 and beta-adrenoceptor subtypes and their functional roles in human normal and obstructed bladders. J. Urol. 170(2 Pt 1), 649–653 (2003)

    Article  CAS  PubMed  Google Scholar 

  65. B.A. O'Reilly, A.H. Kosaka, T.K. Chang, A.P. Ford, R. Popert, S.B. McMahon, A quantitative analysis of purinoceptor expression in the bladders of patients with symptomatic outlet obstruction. BJU Int. 87(7), 617–622 (2001a)

    Article  CAS  PubMed  Google Scholar 

  66. B.A. O'Reilly, A.H. Kosaka, T.K. Chang, A.P. Ford, R. Popert, J.M. Rymer, S.B. McMahon, A quantitative analysis of purinoceptor expression in human fetal and adult bladders. J. Urol. 165(5), 1730–1734 (2001b)

    Article  CAS  PubMed  Google Scholar 

  67. T. Ogawa, R. Sakakibara, S. Kuno, O. Ishizuka, T. Kitta, N. Yoshimura, Prevalence and treatment of LUTS in patients with Parkinson disease or multiple system atrophy. Nat. Rev. Urol. 14(2), 79–89 (2016)

    Article  PubMed  Google Scholar 

  68. S. Palea, W. Artibani, E. Ostardo, D.G. Trist, C. Pietra, Evidence for purinergic neurotransmission in human urinary bladder affected by interstitial cystitis. J. Urol. 150(6), 2007–2012 (1993)

    Article  CAS  PubMed  Google Scholar 

  69. R. Pehrson, K.E. Andersson, Effects of tiagabine, a gamma-aminobutyric acid re-uptake inhibitor, on normal rat bladder function. J. Urol. 167(5), 2241–2246 (2002)

    Article  CAS  PubMed  Google Scholar 

  70. R. Pehrson, A. Lehmann, K.E. Andersson, Effects of gamma-aminobutyrate B receptor modulation on normal micturition and oxyhemoglobin induced detrusor overactivity in female rats. J. Urol. 168(6), 2700–2705 (2002)

    Article  CAS  PubMed  Google Scholar 

  71. H. Petit, L. Wiart, E. Gaujard, F. Le Breton, J.M. Ferriere, A. Lagueny, P.A. Joseph, M. Barat, Botulinum A toxin treatment for detrusor-sphincter dyssynergia in spinal cord disease. Spinal Cord 36(2), 91–94 (1998)

    Article  CAS  PubMed  Google Scholar 

  72. B. Schurch, D. Hauri, B. Rodic, A. Curt, M. Meyer, A.B. Rossier, Botulinum-A toxin as a treatment of detrusor-sphincter dyssynergia: A prospective study in 24 spinal cord injury patients. J. Urol. 155(3), 1023–1029 (1996)

    Article  CAS  PubMed  Google Scholar 

  73. B. Schurch, M. Stohrer, G. Kramer, D.M. Schmid, G. Gaul, D. Hauri, Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: A new alternative to anticholinergic drugs? Preliminary results. J. Urol. 164(3 Pt 1), 692–697 (2000)

    Article  CAS  PubMed  Google Scholar 

  74. S. Seki, Y. Igawa, K. Kaidoh, O. Ishizuka, O. Nishizawa, K.E. Andersson, Role of dopamine D1 and D2 receptors in the micturition reflex in conscious rats. Neurourol. Urodyn. 20(1), 105–113 (2001)

    Article  CAS  PubMed  Google Scholar 

  75. S.J. Shefchyk, Sacral spinal interneurones and the control of urinary bladder and urethral striated sphincter muscle function. J. Physiol. 533(Pt 1), 57–63 (2001)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  76. T. Shibata, M. Watanabe, R. Ichikawa, Y. Inoue, T. Koyanagi, Different expressions of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid and N-methyl-D-aspartate receptor subunit mRNAs between visceromotor and somatomotor neurons of the rat lumbosacral spinal cord. J. Comp. Neurol. 404(2), 172–182 (1999)

    Article  CAS  PubMed  Google Scholar 

  77. C.P. Smith, M.B. Chancellor, Emerging role of botulinum toxin in the management of voiding dysfunction. J. Urol. 171(6 Pt 1), 2128–2137 (2004)

    Article  CAS  PubMed  Google Scholar 

  78. C.P. Smith, M.E. Franks, B.K. McNeil, R. Ghosh, W.C. de Groat, M.B. Chancellor, G.T. Somogyi, Effect of botulinum toxin a on the autonomic nervous system of the rat lower urinary tract. J. Urol. 169(5), 1896–1900 (2003)

    Article  CAS  PubMed  Google Scholar 

  79. C.P. Smith, J. Nishiguchi, M. O'Leary, N. Yoshimura, M.B. Chancellor, Single-institution experience in 110 patients with botulinum toxin A injection into bladder or urethra. Urology 65(1), 37–41 (2005)

    Article  PubMed  Google Scholar 

  80. W.D. Steers, W.C. de Groat, Effects of m-chlorophenylpiperazine on penile and bladder function in rats. Am. J. Physiol. 257, R1441–R1449 (1989)

    CAS  PubMed  Google Scholar 

  81. K. Takezawa, M. Kondo, H. Kiuchi, N. Ueda, T. Soda, S. Fukuhara, T. Takao, Y. Miyagawa, A. Tsujimura, K. Matsumoto-Miyai, Y. Ishida, H. Negoro, O. Ogawa, N. Nonomura, S. Shimada, Authentic role of ATP signaling in micturition reflex. Sci. Rep. 6, 19585 (2016)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  82. K. Takezawa, M. Kondo, N. Nonomura, S. Shimada, Urothelial ATP signaling: What is its role in bladder sensation? Neurourol. Urodyn. 36(4), 966–972 (2017)

    Article  CAS  PubMed  Google Scholar 

  83. M.C. Truss, A.J. Becker, S. Uckert, D. Schultheiss, S. Machtens, U. Jonas, C.G. Stief, Selective pharmacological manipulation of the smooth muscle tissue of the genitourinary tract: A glimpse into the future. BJU Int. 83 Suppl 2, 36–41 (1999)

    CAS  PubMed  Google Scholar 

  84. M.C. Truss, C.G. Stief, S. Uckert, A.J. Becker, J. Wefer, D. Schultheiss, U. Jonas, Phosphodiesterase 1 inhibition in the treatment of lower urinary tract dysfunction: From bench to bedside. World J. Urol. 19(5), 344–350 (2001)

    Article  CAS  PubMed  Google Scholar 

  85. P. Tyagi, M. Kashyap, N. Yoshimura, M. Chancellor, C.J. Chermansky, Past, present and future of chemodenervation with botulinum toxin in the treatment of overactive bladder. J. Urol. 197(4), 982–990 (2016)

    Article  PubMed  PubMed Central  Google Scholar 

  86. O. Yokoyama, M. Yoshiyama, M. Namiki, W.C. de Groat, Glutamatergic and dopaminergic contributions to rat bladder hyperactivity after cerebral artery occlusion. Am. J. Phys. 276(4 Pt 2), R935–R942 (1999)

    CAS  Google Scholar 

  87. M. Yono, H.E. Foster Jr., D. Shin, W. Takahashi, M. Pouresmail, J. Latifpour, Doxazosin-induced up-regulation of alpha 1A-adrenoceptor mRNA in the rat lower urinary tract. Can. J. Physiol. Pharmacol. 82(10), 872–878 (2004)

    Article  CAS  PubMed  Google Scholar 

  88. N. Yoshimura, W.C. de Groat, Neural control of the lower urinary tract. Int. J. Urol. 4(2), 111–125 (1997)

    Article  CAS  PubMed  Google Scholar 

  89. N. Yoshimura, S.L. Erdman, M.W. Snider, W.C. de Groat, Effects of spinal cord injury on neurofilament immunoreactivity and capsaicin sensitivity in rat dorsal root ganglion neurons innervating the urinary bladder. Neuroscience 83(2), 633–643 (1998)

    Article  CAS  PubMed  Google Scholar 

  90. N. Yoshimura, S. Kuno, M.B. Chancellor, W.C. De Groat, S. Seki, Dopaminergic mechanisms underlying bladder hyperactivity in rats with a unilateral 6-hydroxydopamine (6-OHDA) lesion of the nigrostriatal pathway. Br. J. Pharmacol. 139(8), 1425–1432 (2003)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  91. N. Yoshimura, E. Mizuta, S. Kuno, M. Sasa, O. Yoshida, The dopamine D1 receptor agonist SKF 38393 suppresses detrusor hyperreflexia in the monkey with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Neuropharmacology 32(4), 315–321 (1993)

    Article  CAS  PubMed  Google Scholar 

  92. N. Yoshimura, E. Mizuta, O. Yoshida, S. Kuno, Therapeutic effects of dopamine D1/D2 receptor agonists on detrusor hyperreflexia in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned parkinsonian cynomolgus monkeys. J. Pharmacol. Exp. Ther. 286(1), 228–233 (1998)

    CAS  PubMed  Google Scholar 

  93. M. Yoshiyama, W.C. de Groat, Supraspinal and spinal alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid and N-methyl-D-aspartate glutamatergic control of the micturition reflex in the urethane-anesthetized rat. Neuroscience 132(4), 1017–1026 (2005)

    Article  CAS  PubMed  Google Scholar 

  94. M. Yoshiyama, J.R. Roppolo, W.C. de Groat, Effects of LY215490, a competitive AMPA receptor antagonist, on the micturition reflex in the rat. J. Pharmacol. Exp. Ther. 280, 894–904 (1997)

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Naoki Yoshimura .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2023 Springer Nature Singapore Pte Ltd.

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Yoshimura, N., Takaoka, E., Suzuki, T., Kwon, J. (2023). Pharmacology of the Lower Urinary Tract. In: Liao, L., Madersbacher, H. (eds) Handbook of Neurourology. Springer, Singapore. https://doi.org/10.1007/978-981-99-1659-7_8

Download citation

  • DOI: https://doi.org/10.1007/978-981-99-1659-7_8

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-99-1658-0

  • Online ISBN: 978-981-99-1659-7

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics